HOUSTON--(BUSINESS WIRE)--Aug. 28, 2006--IDEV Technologies, Inc., an emerging leader in the development and marketing of minimally invasive stent technologies, announced today that the company received a 510(k) clearance from FDA for the first interwoven nitinol self-expanding stent available in the United States for palliative treatment of malignant strictures in the biliary tree. The newly approved SureSave(TM) Stent will be renamed SUPERA(TM).
